Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes. [PDF]
Prampolini B +2 more
europepmc +1 more source
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data [PDF]
Pedro Filipe Teixeira +18 more
openalex +1 more source
This research presents a novel implantable bio‐battery, GF‐OsG, tailored for diabetic bone repair. GF‐OsG generates microcurrents in high‐glucose conditions to enhance vascularization, shift macrophages to the M2 phenotype, and regulate immune responses.
Nanning Lv +10 more
wiley +1 more source
Fulminant type 1 diabetes: A distinct subtype of type 1 diabetes mellitus
Jiao Fu, Bing-Yin Shi
doaj +1 more source
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. [PDF]
You L +11 more
europepmc +1 more source
Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee +4 more
wiley +1 more source
Translation, Cultural Adaptation, and Validation of the Arabic Version of the Type 1 Diabetes Distress Scale (T1-DDS) Among Adults with Type 1 Diabetes in Saudi Arabia. [PDF]
Alguwaihes AM, Alenezi S.
europepmc +1 more source
The insulin polymorphism -23Hph increases the risk for type 1 diabetes mellitus in the Romanian population [PDF]
Dănuţ Cimponeriu +7 more
openalex +1 more source
An oral nanoplatform, MOP@T@D, which can maintain glucose homeostasis and restore islet β cells in diabetic rats is developed. It achieves efficient intestinal absorption and liver‐targeted delivery. The nanoparticle disintegrates only in response to hyperglycemia to release insulin on demand and provides antioxidant protection through selenoprotein ...
Chenxiao Chu +14 more
wiley +1 more source
Pathogenesis and advances in immunotherapy for type 1 diabetes treatment. [PDF]
Linh TC, Dung NK.
europepmc +1 more source

